Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Think Research Corporation V.THNK

Think Research Corporation is a Canada-based company that offers digital health software solutions. It is a provider of cloud-based data, knowledge, and software solutions primarily delivered as software-as-a-service (SaaS) to healthcare delivery systems and the practitioners that they support. Its operations are organized into three lines of business: Software and Data Solutions, Clinical Research, and Clinical Services. Its SaaS solutions help patients find, navigate, and connect to health services across large governments and payer clients, while also ensuring safety for prescribed medications at pharmacies. Through its wholly owned subsidiary, BioPharma Services Inc., the Company provides research data and analysis derived from Phase I clinical trials, bioequivalence studies and bioanalytical services. Its clinics act as a test bed for its software and technology, transforming them with digital solutions that optimize clinical outcomes, streamline workflows, and optimize billing.


TSXV:THNK - Post by User

Comment by Possibleidiot01on May 30, 2023 7:00am
76 Views
Post# 35469758

RE:AS good as can be expected

RE:AS good as can be expectedStill work to be done but there's that  saying ,"“A thousand-mile journey begins with the first step."
The Company generated gross margin of 52% in Q1 2023 compared to 45% for the same period in the prior year. This improvement in gross margin was primarily affected by the change in revenue mix as a result of the higher proportion of Software and Data Solutions revenue in the quarter.
Adjusted EBITDA Margin was 5% in Q1 of 2023 compared to (1%) in Q1 of 2022.

The next section is a little confusing to me ; maybe it's stock based compensation related

In Q1 2023, operating expenses excluding depreciation, amortization and stock-based compensation increased by 20% to $10.3M compared sequentially to $8.6M in Q4 2022. These expenses increased to 47% of revenue in Q1 compared to 40% of revenue in Q4 2022.Think recorded certain one-time annual cost adjustments in the fourth quarter of 2022 such that the total operating expenses recorded for that period were below the expected baseline operating expenses in future quarters

<< Previous
Bullboard Posts
Next >>